Novavax starts Phase 1 clinical trial of coronavirus vaccine candidate

57

Novavax Inc said on Monday it has started the Phase 1 clinical trial of a novel coronavirus vaccine candidate and has enrolled the trial’s first participants, with preliminary results slated for July.

Subscribe:…